KS

Kalawati Sambhaji Aher

Active Director Designated Partner DIN 10016422
DIN 10016422 First appointment Aug 2022 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Kalawati Sambhaji Aher

Data last updated:

Kalawati Sambhaji Aher is a Designated Partner at Issas Pharma Llp (since 2022). The company operates in Paper.

DIN 10016422
Primary Designation Designated Partner
Industry Paper
First Appointment 20 Aug 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Issas Pharma Llp ABC-1593
Designated Partner20 Aug 20222022Active

Board colleagues of Kalawati Sambhaji Aher

NameDINCompanyDesignation
Prashant Sambhaji Aher08568130Issas Pharma LlpDesignated Partner
Sandeep Sambaji Aher05120124Issas Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Issas Pharma Llp
Premium access

Shareholding and investment profile for Kalawati Sambhaji Aher

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalawati Sambhaji Aher

Kalawati Sambhaji Aher currently holds 1 directorship: Issas Pharma Llp (Designated Partner, since 20 Aug 2022).

Kalawati Sambhaji Aher was first appointed on 20 Aug 2022 as Designated Partner at Issas Pharma Llp.

The current boards of Kalawati Sambhaji Aher's companies include Prashant Sambhaji Aher (Issas Pharma Llp), Sandeep Sambaji Aher (Issas Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available